Integer Holdings is no longer a public-market compounder debate. The equity is a cash takeout whose remaining spread prices a near-certain close against a contract manufacturer that already lost the growth narrative that once supported a richer multiple. An affiliate of funds managed by KKR agreed in early August to buy the company for a fixed cash consideration of $127 a share. That price sits barely above the recent close near $126, which tells the tape that residual close risk is treated as thin. The live question is whether that thin spread is honest pay for a break that would dump holders back into a franchise whose electrophysiology ramps disappointed and whose outlook is already withdrawn.
The mechanism that matters is not the headline premium. It is the way the board converted a growth disappointment into a liquidity event. On the last session of April, before the strategic-review announcement, the stock closed at $83.67. That print followed a first-quarter update that cut the sales outlook and conceded that two new electrophysiology products were not ramping as customers had forecast. A board-led review then ran through the summer and produced a single buyer with committed equity, committed debt, and no financing condition. The August merger agreement therefore monetizes the franchise at the moment public holders had already marked down the growth algorithm. Investors who held through the review capture a large premium to the unaffected price. Investors who buy the spread today capture almost none of that premium and inherit only close risk.
The tension is asymmetry. A close delivers a thin remaining gross spread from the recent tape. A break reopens a standalone that the market last valued in the mid-eighties before any review, and that still carries electrophysiology forecast risk, inventory build, and leverage already at the high end of management's own target band. The reverse termination fee payable by the buyer is $307 million if the parent fails to close when required. The company termination fee is $154 million if Integer walks for a superior proposal. Those fees tilt the economics toward completion, but they do not recapitalize public holders if antitrust review or a material adverse effect actually stops the merger. The strongest bear case is not that KKR overpaid. It is that the public tape now behaves as if break probability is near zero while the operating print still looks like the reason the board sold.
What resolves the tape is not another quarterly sales print. It is the stockholder vote and the remaining regulatory clearances, with an outside date of May 2, 2027 and company commentary that pointed to a year-end close. Until those conditions clear, every operating data point matters mainly as a window into what the residual franchise is worth if the merger does not complete.